Skip to main content

SANUWAVE Health, Inc.

SNWV
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001417663

No open-market purchases or sales by SANUWAVE Health, Inc. insiders were filed in the last 90 days; 49 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by SANUWAVE Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for SANUWAVE Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for SANUWAVE Health, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Blizard JeffreyDirector–Jul 2, 20264
Miller Ian D.Director48,426Jul 2, 20264
Bazar Gregory MatthewDirector–Jul 2, 20264
Tyler JamesDirector8,700Jul 2, 20264
Frank Morgan C.Chief Executive Officer63,999IndirectJul 2, 20267
Opaleye Management Inc.10% Owner5,000IndirectMay 4, 20264
Wern David TimothyExec VP of Sales–Feb 3, 20261
Manchester Management Co LLCOther: Director by Deputization63,999IndirectDec 15, 20252
Manchester Explorer, L.P.Other: Director by Deputization63,999IndirectDec 15, 20252
Besser James EOther: Director by Deputization63,999IndirectDec 15, 20252
Manchester Management PR, LLCOther: Director by Deputization63,999IndirectDec 15, 20252
Stolarski Anthony MichaelDirector351,786Jun 12, 20250
Stegagno PeterChief Operating Officer2,032Jun 9, 20250
Cioanta IulianChief Sci. and Tech. Officer41May 16, 20250
Sorensen PeterChief Financial Officer–Feb 7, 20250
Gilmore NanciChief Commercial Officer–Feb 7, 20250
Walko AndrewPresident–Oct 23, 20240
Hendricks TimothyExecutive VP of Sales–Oct 23, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 4, 2026 (view filing)Apr 30-May 14 daysOpaleye Management Inc.10% OwnerSSaleCommon Stock, par value $0.001 per share−35.6K$16.14−$574.2K−87.7%5.00K after4 lots
Apr 30, 2026 (view filing)Apr 28-292 daysOpaleye Management Inc.10% OwnerSSaleCommon Stock, par value $0.001 per share−70.6K$18.05−$1.28M−91.6%6.50K after4 lots
Apr 21, 2026 (view filing)Apr 17-214 daysOpaleye Management Inc.10% OwnerSSaleCommon Stock, par value $0.001 per share−16.5K$20.46−$337.0K−1.7%954.8K after3 lots
Dec 15, 2025 (view filing)5:22 PM ETDec 11-124 daysManchester Management Co LLC and 4 othersOther: Director by DeputizationSSaleCommon Stock, par value $0.001−20.0K$27.95−$559.1K−23.8%64.0K after2 lots
Dec 11, 2025 (view filing)3:08 PM ETDec 8-103 daysManchester Management Co LLC and 4 othersOther: Director by DeputizationSSaleCommon Stock, par value $0.001−142.8K$30.72−$4.39M−14.2%864.0K afterAmended3 lots
Dec 11, 2025 (view filing)3:08 PM ETDec 83 daysManchester Management Co LLC and 4 othersOther: Director by DeputizationSSaleCommon Stock, par value $0.001−2.00K$31.60−$63.2K−50.0%2.00K afterAmended
Oct 9, 2025 (view filing)Oct 63 daysLateOpaleye Management Inc.10% OwnerPPurchaseCommon Stock, par value $0.001 per share+1.27K$30.28+$38.4K+0.1%966.3K after
Jun 9, 2025 (view filing)Jun 54 daysStegagno PeterChief Operating OfficerSSale−1.86K$27.71−$51.6K−47.8%2.03K after
May 16, 2025 (view filing)May 151 dayCioanta IulianChief Sci. and Tech. OfficerSSale−3.64K$31.60−$115.0K−98.9%41 after
Apr 30, 2025 (view filing)Apr 291 dayOpaleye Management Inc.10% OwnerPPurchaseCommon Stock, par value $0.001 per share+8.00K$25.49+$203.9K+114.2%15.0K after2 lots
Nov 1, 2024 (view filing)Oct 30-Nov 12 daysOpaleye Management Inc.10% OwnerPPurchaseCommon Stock, par value $0.001 per share+27.9K$15.75+$438.9KNew position12.0K after5 lots
Oct 23, 2024 (view filing)1:03 PM ETOct 185 daysLateManchester Management Co LLC and 4 othersOther: Director by DeputizationPPurchaseCommon Stock, par value $0.001+181.8K$8.25+$1.50M+22.0%1.01M after